West Nile virus and plasma-derived medicinal products - Scientific guideline

This document addresses the viral safety of plasma-derived medicinal products with respect to West-Nile virus (WNV).

Keywords: Viral safety, plasma-derived medicinal products, West-Nile virus

Current effective version

CPMP position statement on West Nile virus and plasma-derived medicinal products

AdoptedReference Number: EMEA/CPMP/BWP/3752/03/adoptedLegal effective date: 25/07/2003